Provided by Tiger Trade Technology Pte. Ltd.

Roundhill GLP-1 & Weight Loss ETF

29.93
-0.2559-0.85%
Post-market: 29.950.0121+0.04%19:30 EDT
Volume:9K
Turnover:279.68K
Market Cap:55.97M
PE:- -
High:30.22
Open:30.22
Low:29.84
Close:30.19
52wk High:37.15
52wk Low:27.34
Shares:1.87M
Float Shares:1.87M
Volume Ratio:0.84
T/O Rate:0.50%
Dividend:0.41
Dividend Rate:1.37%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Cboe data shows mixed options sentiment in Novo Nordisk with shares down 7.85%

TIPRANKS
·
Sep 21

Novo Nordisk Says New Obesity Drug Outperformed Lilly's Zepbound in Phase 3 Trial

Dow Jones
·
Sep 21

Novo Nordisk A/S Stock (NVO) Moved Down by 7.86% on Sep 21: A Full Analysis

TradingKey
·
Sep 21

Novo Stock (NVO) Sinks Despite Beating Eli Lilly in New CagriSema Obesity Trial

TIPRANKS
·
Sep 21

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 21

Sector Update: Healthcare

MT Newswires Live
·
Sep 21

Update: Oil Price Decline Lifts US Equity Futures Pre-Bell

MT Newswires Live
·
Sep 21

Why Novo Stock is Dropping After Drugmaker Unveils Ambitious Growth Plan

Dow Jones
·
Sep 21

【US Pre-Market】US-China Talks Boost Markets, Bitcoin Rises to $85,000, Greenland Concept Stocks Surge, Oil Falls for Fourth Day

TradingKey
·
Sep 21

Oura Files for Initial Public Offering on Nasdaq

MT Newswires Live
·
Sep 21

Novo Nordisk's Weight-Loss, Diabetes Drug Candidate Meets Primary Goals

MT Newswires Live
·
Sep 21

Goldman Sachs Sticks to Their Hold Rating for Novo Nordisk (0QIU)

TIPRANKS
·
Sep 21

Smart Ring Maker Oura Eyes $15.6 Billion IPO Valuation in Fall Listings Demand Test

Reuters
·
Sep 21

Oura - Eli Lilly Interested in Purchasing up to $100 Mln; Dragoneer up to $300 Mln in IPO - SEC Filing

THOMSON REUTERS
·
Sep 21

Novo Says Its Next-Gen Obesity Drug Tops Lilly Rival in Late-Stage Study

Reuters
·
Sep 21

Why Is Novo Stock (NVO) Falling in Pre-Market Today, September 21?

TIPRANKS
·
Sep 21

Novo Nordisk Drops Over 7% Pre-Market as Wegovy Sales Miss Expectations

TradingKey
·
Sep 21

Market Chatter: Novo Nordisk Urged by Shareholders to Develop New Medicines, Pursue Acquisitions

MT Newswires Live
·
Sep 21

Pfizer Agrees to Share Incremental Overseas Drug Revenue With HHS

MT Newswires Live
·
Sep 21

Novo Nordisk Aims for $23 Billion in 2035 Pipeline Sales

MT Newswires Live
·
Sep 21